Intersect ENT Reports Second Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Intersect ENT (XENT) Tops Q2 EPS by 3c, FY Revenue Guidance Misses
August 1, 2018 8:41 AM EDTIntersect ENT (NASDAQ: XENT) reported Q2 EPS of ($0.14), $0.03 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $26.3 million versus the consensus estimate of $28.15 million.
Outlook
The company expects to achieve third quarter revenue in the range of $23.8 to $24.3 million,... More
